Skip to main content

Table 1 Comparison between targeted cancer genes tested in FoundationOne (FOne) (n = 315) test and FoundationACT (FACT) (n = 62) assays

From: Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors

  1. Bold highlights the genes that are tested in both FoundationACT and FoundationOne. E, genes with entire coding sequence coverage (n = 27); S, genes with selected, critical exon coverage. Blue highlights the rearranged genes tested in both FoundationACT and FoundationOne assays (n = 6). A, genes that were evaluable for copy number amplification